definiens: means any decision that with respect to a Collaboration Antibody or Development Candidate prior to the date of Completion of GLP / Toxicity Studies involving that Collaboration Antibody or Development Candidatc, 1.39 means all Development activities with respect to a Devclopment Candidate conducted by or on behalf of Enumeral as specified in any Development Plan, 1.40 ' means the rate per full time equivalent ( ), \\·hich will be deemed to be [ 1872 ] hOllrs of research or development time per annum for Enumeral FTEs engaged in the conduct of Rescarch Activities or Development Activities, \vhich rate will be equal to lthree hundred and fifty thousand dollars ( $ 350,000 ) ] . The above FTE Rate \vill be 6 FOIA CONFIDENTIAL TREAT : YIENT REQLESTED BY E:'<UMERAL BIOMEDICAL HOLDINGS, INC